Invention Grant
- Patent Title: Beta lactamase as biomarker for the specific detection of tuberculosis-complex bacteria
-
Application No.: US15504633Application Date: 2015-08-17
-
Publication No.: US10175239B2Publication Date: 2019-01-08
- Inventor: Jeffrey D. Cirillo , Michael T. Norman
- Applicant: The Texas A&M University System
- Applicant Address: US TX College Station
- Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
- Current Assignee: THE TEXAS A&M UNIVERSITY SYSTEM
- Current Assignee Address: US TX College Station
- Agency: Chirstensen O'Connor Johnson Kindness PLLC
- International Application: PCT/US2015/045572 WO 20150817
- International Announcement: WO2016/028712 WO 20160225
- Main IPC: C12N9/86
- IPC: C12N9/86 ; C12Q1/04 ; G01N33/573 ; G01N33/569 ; C07K16/12 ; C07K16/40 ; C12Q1/689 ; G01N33/68
Abstract:
The present disclosure provides methods, reagents, systems, and devices that target β lactamase as a biomarker for the sensitive and specific detection of tuberculosis-complex bacteria. Specifically, the present disclosure relates to methods and compositions for the detection of specific β-lactamase protein and nucleic acid sequences to indicate the presence of tuberculosis-complex bacteria.
Public/Granted literature
- US20170350890A1 BETA LACTAMASE AS BIOMARKER FOR THE SPECIFIC DETECTION OF TUBERCULOSIS-COMPLEX BACTERIA Public/Granted day:2017-12-07
Information query
IPC分类:
